INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

Search

Biotage AB

Abierto

140.6 -0.64

Resumen

Variación precio

24h

Actual

Mínimo

140.1

Máximo

141.5

Métricas clave

By Trading Economics

Ingresos

97M

158M

Ventas

92M

582M

P/B

Media del Sector

25.507

20.525

BPA

1.416

Rentabilidad por dividendo

1.82

Margen de beneficios

27.148

Empleados

680

EBITDA

111M

222M

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.82%

4.36%

Próximas Ganancias

16 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-3.9B

7.2B

Apertura anterior

141.24

Cierre anterior

140.6

Biotage AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 abr 2025, 06:50 UTC

Adquisiciones, fusiones, absorciones

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22 abr 2025, 06:04 UTC

Adquisiciones, fusiones, absorciones

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 abr 2025, 06:03 UTC

Adquisiciones, fusiones, absorciones

KKR: Biotage Board Recommends Shareholders Accept Offer

22 abr 2025, 06:02 UTC

Adquisiciones, fusiones, absorciones

KKR: Offer Values Biotage at SEK11.61B

22 abr 2025, 06:02 UTC

Adquisiciones, fusiones, absorciones

KKR Makes SEK145 a Share Bid For Biotage

Comparación entre iguales

Cambio de precio

Biotage AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.